The device, which is delivered transapically, represents an option for very sick patients who previously have had none.

Abbott reported new study findings supporting the use of its Tendyne transcatheter mitral valve replacement (TMVR) system.

A novel technology called intravascular lithotripsy-facilitated percutaneous balloon mitral valvuloplasty (IVL-PBMV) shows promise for treating patients with severe calcific mitral stenosis (MS) and ...

Mitral valve stenosis is a form of valvular heart disease. It occurs when there is a narrowing of the mitral valve, which restricts the flow of blood from the left atrium to the left ventricle. Mitral ...

The US Food and Drug Administration has approved the Tendyne transcatheter mitral valve replacement (TMVR) system for the treatment of patients with mitral valve dysfunction, device manufacturer ...

NEW YORK CITY -- Heart valve innovation has made polymer valves a reality, with one such device boasting good 1-year outcomes in a small single-arm study. Adults who received the Tria device for ...